MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic is a research paper published in Frontiers in Cell and Developmental Biology (2021). On theSindex it has a DataRank of 0. It has been cited 185 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA240290
NCI NIH HHS
Grant: R21 CA218635
NCI NIH HHS
Grant: R01 CA237027
NCI NIH HHS
Grant: P30 CA016056
NCI NIH HHS
Grant: R01 CA222959
NCI NIH HHS
Grant: R35 CA232105
NCI NIH HHS
Grant: R01 CA205420
NCI NIH HHS
Grant: R01 CA226259
NCI NIH HHS
Grant: R21 CA237939
National Institutes of Health
Grant: 5R01CA226259-08
Ligand-mediated, vehicle-free delivery of small RNAs
National Institutes of Health
Grant: 5R35CA232105-02
Precision microRNA medicine in cancer
National Institutes of Health
Grant: 1R21CA218635-01A1
Slow-cycling cells, therapy resistance and clinical implications in prostate cancer
National Institutes of Health
Grant: 1R01CA240290-01
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
National Institutes of Health
Grant: 5R01CA222959-04
Mechanism of Intratumoral Transport of Particulate Drugs
National Institutes of Health
Grant: 5R01CA205420-07
Enhancing miRNA Therapeutics through Vehicle Free Delivery
National Institutes of Health
Grant: 5R01CA237027-03
Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC
National Institutes of Health
Grant: 1R21CA237939-01A1
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
FWCI
8.90
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals